Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Tandem Diabetes Care, Inc.

Capitalization 1.48B 1.29B 1.16B 1.11B 2.03B 136B 2.11B 13.92B 5.52B 65.19B 5.54B 5.42B 235B P/E ratio 2026 *
-26.5x
P/E ratio 2027 * -10,583x
Enterprise value 1.48B 1.29B 1.17B 1.12B 2.03B 137B 2.11B 13.93B 5.52B 65.23B 5.54B 5.42B 236B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.13x
Free-Float
99.23%
Yield 2026 *
-
Yield 2027 * -
1 day+3.43%
1 week+2.13%
Current month-14.66%
1 month+13.93%
3 months+0.94%
6 months+75.96%
Current year-1.77%
1 week 20.17
Extreme 20.17
22.54
1 month 17.71
Extreme 17.71
29.65
Current year 17.71
Extreme 17.71
29.65
1 year 9.98
Extreme 9.98
29.65
3 years 9.98
Extreme 9.98
53.69
5 years 9.98
Extreme 9.98
155.86
10 years 2.14
Extreme 2.14
155.86
Manager TitleAgeSince
Chief Executive Officer 70 28/02/2019
Director of Finance/CFO 53 31/12/2017
Compliance Officer 60 31/12/2021
Director TitleAgeSince
Chairman 65 28/02/2023
Director/Board Member 66 30/06/2013
Director/Board Member 70 31/05/2019
Change 5d. change 1-year change 3-years change Capi.($)
+3.43%+2.13%+18.76%-45.92% 1.48B
-0.10%-1.40%-16.83%+10.02% 188B
-0.27%-4.14%-5.62%+11.75% 112B
-0.77%-2.37%+36.69%+135.86% 68.08B
+0.22%-2.61%+61.42%+96.57% 58.59B
-0.17%-4.64%-28.47%-31.13% 45.38B
+0.95%-5.41% - - 33.65B
-1.56%-5.67%-6.19%-41.95% 24.72B
+1.05%-6.92%-3.54%+20.14% 21.04B
+1.32%+0.51%-24.04%+16.51% 19.15B
Average +0.41%-3.05%+3.58%+19.09% 57.17B
Weighted average by Cap. -0.09%-2.98%+0.66%+30.34%

Financials

2026 *2027 *
Net sales 1.08B 940M 849M 812M 1.48B 99.45B 1.54B 10.14B 4.02B 47.51B 4.03B 3.95B 172B 1.2B 1.05B 949M 907M 1.65B 111B 1.72B 11.33B 4.49B 53.08B 4.51B 4.41B 192B
Net income -56.19M -49.12M -44.37M -42.45M -77.21M -5.2B -80.26M -530M -210M -2.48B -211M -206M -8.97B -1.06M -925K -836K -799K -1.45M -97.86M -1.51M -9.98M -3.96M -46.75M -3.97M -3.89M -169M
Net Debt 898K 785K 709K 678K 1.23M 83.04M 1.28M 8.47M 3.36M 39.67M 3.37M 3.3M 143M -113M -98.64M -89.12M -85.25M -155M -10.44B -161M -1.06B -422M -4.99B -423M -415M -18.01B
Logo Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Employees
2,500
Date Price Change Volume
13/03/26 21.59 $ +3.43% 2,052,055
12/03/26 20.88 $ -5.80% 1,419,067
11/03/26 22.16 $ +1.28% 1,931,755
10/03/26 21.88 $ +4.79% 1,533,314
09/03/26 20.88 $ -1.23% 2,097,599
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
21.59USD
Average target price
29.59USD
Spread / Average Target
+37.06%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW